Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
54
2024
2949
3.860
Why?
Hematopoietic Stem Cell Transplantation
8
2024
555
1.010
Why?
Antibodies, Bispecific
5
2024
74
1.000
Why?
Leukemia, Plasma Cell
2
2020
33
0.870
Why?
Immunotherapy, Adoptive
5
2024
162
0.720
Why?
Neoplasms, Plasma Cell
3
2024
37
0.650
Why?
Chromosome Deletion
2
2023
140
0.580
Why?
Bone Marrow
9
2022
356
0.570
Why?
Chromosomes, Human, Pair 17
1
2017
36
0.560
Why?
Humans
62
2024
50389
0.560
Why?
Transplantation, Autologous
9
2024
464
0.540
Why?
Clinical Trials as Topic
4
2022
465
0.520
Why?
Tumor Suppressor Protein p53
1
2017
214
0.500
Why?
Proteasome Inhibitors
1
2016
104
0.490
Why?
Immunologic Factors
1
2016
111
0.480
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.480
Why?
B-Cell Maturation Antigen
6
2024
92
0.470
Why?
Plasma Cells
5
2023
221
0.460
Why?
Immunotherapy
1
2016
235
0.450
Why?
Stem Cell Transplantation
5
2024
179
0.440
Why?
Translocation, Genetic
5
2021
263
0.440
Why?
Antibodies, Monoclonal
2
2022
462
0.430
Why?
Gene Expression Regulation, Neoplastic
5
2021
830
0.410
Why?
Mutation
6
2022
1292
0.400
Why?
Prognosis
13
2024
1979
0.400
Why?
Aged
19
2024
9590
0.390
Why?
Neutropenia
2
2023
114
0.390
Why?
Survival Analysis
8
2024
671
0.390
Why?
Neoplasms
2
2012
1237
0.380
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.380
Why?
Lymphocytes
1
2012
154
0.370
Why?
Gene Expression Profiling
8
2023
1029
0.360
Why?
Cancer Vaccines
1
2011
78
0.350
Why?
Evolution, Molecular
2
2021
97
0.350
Why?
Neoplasm, Residual
5
2022
161
0.350
Why?
Neoplasm Recurrence, Local
6
2024
634
0.320
Why?
Cytokines
1
2012
606
0.320
Why?
Tumor Microenvironment
3
2024
223
0.300
Why?
Hematologic Neoplasms
2
2022
99
0.290
Why?
Neoplasm Proteins
3
2020
321
0.290
Why?
Combined Modality Therapy
4
2024
641
0.270
Why?
Atrial Fibrillation
2
2022
189
0.270
Why?
Female
23
2024
26981
0.260
Why?
Middle Aged
17
2024
12460
0.240
Why?
Aged, 80 and over
7
2024
3180
0.240
Why?
Fluorodeoxyglucose F18
4
2021
190
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Neoplasms, Second Primary
1
2024
74
0.220
Why?
Treatment Outcome
8
2024
5230
0.220
Why?
Male
21
2024
25718
0.220
Why?
Chromosomes, Human, Pair 1
2
2023
92
0.210
Why?
Positron-Emission Tomography
3
2022
289
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1003
0.210
Why?
Adult
14
2024
13568
0.200
Why?
Risk Factors
9
2024
3692
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
78
0.200
Why?
Paraproteinemias
1
2022
72
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
Osteolysis
1
2022
75
0.200
Why?
Drug Approval
1
2022
47
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Patient Participation
1
2022
68
0.190
Why?
T-Lymphocytes
4
2024
331
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Cell Cycle
1
2021
227
0.170
Why?
Practice Guidelines as Topic
1
2023
460
0.170
Why?
Disease Progression
5
2021
823
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Bone Resorption
1
2022
302
0.170
Why?
Bone Diseases
1
2021
97
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Chromosomal Instability
1
2019
16
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
Antigens, CD
1
2020
216
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
279
0.160
Why?
Spleen
1
2019
170
0.150
Why?
Spinal Fractures
1
2018
37
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Antineoplastic Agents
2
2024
1178
0.150
Why?
Bacteremia
1
2019
90
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Gene Rearrangement
1
2018
74
0.140
Why?
Recurrence
4
2024
664
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Epigenesis, Genetic
1
2020
374
0.140
Why?
Pelvis
1
2017
67
0.140
Why?
Cell Proliferation
4
2023
989
0.140
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
104
0.130
Why?
Immunoglobulin Light Chains
1
2017
82
0.130
Why?
Retrospective Studies
6
2024
6223
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Gene Expression
1
2018
613
0.130
Why?
Animals
4
2024
13173
0.120
Why?
Cystatin M
2
2024
19
0.110
Why?
Cross-Sectional Studies
3
2023
1590
0.110
Why?
Disease-Free Survival
3
2019
450
0.100
Why?
Survival Rate
3
2020
915
0.100
Why?
Cardiovascular Diseases
1
2017
455
0.100
Why?
Lymphoma, Non-Hodgkin
1
2011
58
0.090
Why?
Disease Models, Animal
1
2016
1419
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
256
0.090
Why?
Alleles
2
2021
253
0.090
Why?
Genomics
2
2023
284
0.080
Why?
Tumor Burden
2
2020
131
0.080
Why?
Histones
2
2021
296
0.080
Why?
Vaccination
1
2011
275
0.080
Why?
Transcription Factors
2
2023
566
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.080
Why?
Radiopharmaceuticals
2
2021
205
0.080
Why?
Brain Neoplasms
1
2011
288
0.080
Why?
Models, Biological
1
2011
723
0.070
Why?
Cell Differentiation
2
2022
651
0.070
Why?
Transcriptome
2
2020
316
0.070
Why?
Follow-Up Studies
2
2024
2219
0.070
Why?
Kaplan-Meier Estimate
2
2019
466
0.070
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Biopsy
2
2018
592
0.060
Why?
Arkansas
2
2021
1991
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
93
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
123
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
54
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Mice
2
2024
5688
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Signal Transduction
2
2021
1625
0.050
Why?
Patients
1
2022
48
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Patient Selection
1
2023
257
0.050
Why?
United States Food and Drug Administration
1
2022
91
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Bone Marrow Transplantation
1
2022
112
0.050
Why?
Chromosome Aberrations
1
2023
295
0.050
Why?
Dexamethasone
1
2024
437
0.050
Why?
Syndecan-1
1
2021
72
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
RANK Ligand
1
2022
184
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
85
0.050
Why?
Transcriptional Activation
1
2021
121
0.050
Why?
Chromatin
1
2021
138
0.050
Why?
Remission Induction
1
2021
206
0.050
Why?
Clone Cells
1
2021
78
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
224
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Pyrimidines
1
2022
193
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Genome, Human
1
2021
111
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
Health Status Disparities
1
2022
196
0.040
Why?
Genetic Variation
1
2020
215
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Cell Line, Tumor
1
2023
1399
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
168
0.040
Why?
Osteoclasts
1
2022
424
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
Pseudomonas Infections
1
2019
50
0.040
Why?
Syndrome
1
2019
239
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
424
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Oncogene Proteins, Fusion
1
2018
59
0.040
Why?
Protein-Tyrosine Kinases
1
2018
95
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
62
0.040
Why?
Bone and Bones
1
2021
477
0.030
Why?
Glomerular Filtration Rate
1
2017
114
0.030
Why?
Amino Acid Sequence
1
2018
579
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
DNA Methylation
1
2020
551
0.030
Why?
Models, Genetic
1
2016
174
0.030
Why?
Genomic Instability
1
2016
91
0.030
Why?
Staphylococcal Infections
1
2019
269
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Logistic Models
1
2018
900
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Heart
1
2017
336
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Algorithms
1
2018
618
0.030
Why?
Echocardiography
1
2017
398
0.030
Why?
Myocardium
1
2017
444
0.030
Why?
Time Factors
1
2021
2934
0.030
Why?
Disease Management
1
2015
175
0.030
Why?
Longitudinal Studies
1
2016
709
0.030
Why?
Risk Assessment
1
2018
1258
0.030
Why?
Tomography, X-Ray Computed
1
2017
1160
0.020
Why?
United States
1
2022
4913
0.020
Why?
Fatal Outcome
1
2011
195
0.020
Why?
Magnetic Resonance Imaging
1
2017
1534
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description